Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis
December 10, 2024 07:00 ET
|
Relation Therapeutics
FOR IMMEDIATE RELEASERelation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis London, UK, December 10, 2024 – Relation, an industry...
Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis
December 10, 2024 02:00 ET
|
Relation Therapeutics
Relation announces two strategic collaborations with GSK to advance therapeutics for fibrotic diseases and osteoarthritis London, UK, December 10, 2024 – Relation, an industry leader in deploying...
Relation Therapeutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm
March 14, 2024 03:00 ET
|
Relation Therapeutics
Relation Therapeutics secures $35 million of new seed financing led by DCVC and co-lead NVentures, NVIDIA’s venture arm London, March 2024 – Relation Therapeutics, a biotechnology company at the...